Evidence map›Paper›PMID 23660670›Full record

ArticleJournal of biosciences2013

Inactivation of Tor proteins affects the dynamics of endocytic proteins in early stage of endocytosis.

Brandon Tenay, Evin Kimberlin, Michelle Williams, Juliette Denise, Joshua Fakilahyel, Kyoungtae Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of biosciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brandon TenayDepartment of Biology, Missouri State University, 901 South National Ave, Springfield, MO 65897, USA.
Evin Kimberlin
Michelle Williams
Juliette Denise
Joshua Fakilahyel
Kyoungtae Kim

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tor2 is an activator of the Rom2/Rho1 pathway that regulates alpha-factor internalization. Since the recruitment of endocytic proteins such as actin-binding proteins and the amphiphysins precedes the internalization of alpha-factor, we hypothesized that loss of Tor function leads to an alteration in the dynamics of the endocytic proteins. We report here that endocytic proteins, Abp1 and Rvs167, are less recruited to endocytic sites not only in tor2 but also tor1 mutants. Furthermore, we found that the endocytic proteins Rvs167 and Sjl2 are completely mistargeted to the cytoplasm in tor1 delta tor2ts double mutant cells. We also demonstrate here that the efficiency of endocytic internalization or scission in all tor mutants was drastically decreased. In agreement with the Sjl2 mislocalization, we found that in tor1 delta tor2ts double mutant cells, as well as other tor mutant cells, the overall PIP2 level was dramatically increased. Finally, the cell wall chitin content in tor2ts and tor1 delta tor2ts mutant cells was also significantly increased. Taken together, both functional Tor proteins, Tor1 and Tor2, are essentially required for proper endocytic protein dynamics at the early stage of endocytosis.

Indexed as

EndocytosisCell Cycle ProteinsCell MembraneChitinGene Knockout TechniquesMicrofilament ProteinsPhosphatidylinositol 3-KinasesPhosphatidylinositol 4,5-DiphosphatePhosphoric Monoester HydrolasesProtein TransportSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsABP1 protein, S cerevisiaeCell Cycle ProteinsChitinINP52 protein, S cerevisiaeMicrofilament ProteinsPhosphatidylinositol 3-KinasesPhosphatidylinositol 4,5-DiphosphatePhosphoric Monoester HydrolasesRVS167 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsTOR1 protein, S cerevisiaeTOR2 protein, S cerevisiae

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.